{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:30Z","timestamp":1792515750115,"version":"4.5.0"},"reference-count":136,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The immune system and sleep are inextricably linked in both health and pathological conditions. Tightly regulated neuroimmune processes are critical for the physiological maintenance of healthy sleep. Reciprocally, sleep disturbances can detrimentally affect immune homeostasis and predispose to increased risk of autoimmune conditions, which themselves are bidirectionally associated with a higher risk of sleep disturbances. Autoimmune diseases of the central nervous system (CNS), particularly conditions that affect neuroanatomical regions involved in sleep homeostasis and nocturnal respiration, are associated with an increased risk sleep disorders that may impact diagnosis, clinical course, and management. This review summarizes the bidirectional relationship between sleep and immunity and highlights several exemplar autoimmune conditions of the CNS that include sleep disorders as a consequence or diagnostic feature of the disorder.<\/jats:p>","DOI":"10.1055\/a-2559-7565","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T23:08:01Z","timestamp":1744326481000},"page":"420-430","source":"Crossref","is-referenced-by-count":4,"title":["Neuroimmunology and Sleep"],"prefix":"10.1055","volume":"45","author":[{"given":"Brynn K.","family":"Dredla","sequence":"additional","affiliation":[{"name":"Department of Neurology, and Sleep Disorders Center, Mayo Clinic College of Medicine, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-7828","authenticated-orcid":false,"given":"Tiffany J.","family":"Braley","sequence":"additional","affiliation":[{"name":"Divisions of Neuroimmunology and Sleep Medicine, Department of Neurology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrn2576","article-title":"How (and why) the immune system makes us sleep","volume":"10","author":"L Imeri","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1067\/mai.2000.106899","article-title":"Cytokine receptor signaling pathways","volume":"105","author":"W J Leonard","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"R Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2001.tb05826.x","article-title":"The role of cytokines in physiological sleep regulation","volume":"933","author":"J M Krueger","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1073\/pnas.95.6.3251","article-title":"Sympathetic neurons can produce and respond to interleukin 6","volume":"95","author":"P M\u00e4rz","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cne.903370403","article-title":"Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system","volume":"337","author":"C D Breder","year":"1993","journal-title":"J Comp Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.3258444","article-title":"Interleukin-1 immunoreactive innervation of the human hypothalamus","volume":"240","author":"C D Breder","year":"1988","journal-title":"Science"},{"key":"ref8","first-page":"R52","article-title":"Interleukin 1 alters rat sleep: temporal and dose-related effects","volume":"260","author":"M R Opp","year":"1991","journal-title":"Am J Physiol"},{"key":"ref9","first-page":"R453","article-title":"Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever","volume":"260","author":"M R Opp","year":"1991","journal-title":"Am J Physiol"},{"issue":"03","key":"ref10","first-page":"R655","article-title":"Effects of interleukin-1 beta on sleep are mediated by the type I receptor","volume":"274","author":"J Fang","year":"1998","journal-title":"Am J Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.smrv.2017.10.005","article-title":"Tumor necrosis factor alpha in sleep regulation","volume":"40","author":"M D Rockstrom","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1210\/jc.2003-031929","article-title":"Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist","volume":"89","author":"A N Vgontzas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00010.2018","article-title":"The sleep-immune crosstalk in health and disease","volume":"99","author":"L Besedovsky","year":"2019","journal-title":"Physiol Rev"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"D A Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2009.05300.x","article-title":"Effects of sleep and circadian rhythm on the human immune system","volume":"1193","author":"T Lange","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00424-011-1044-0","article-title":"Sleep and immune function","volume":"463","author":"L Besedovsky","year":"2012","journal-title":"Pflugers Arch"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinternmed.2008.505","article-title":"Sleep habits and susceptibility to the common cold","volume":"169","author":"S Cohen","year":"2009","journal-title":"Arch Intern Med"},{"issue":"09","key":"ref19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.5665\/sleep.4968","article-title":"Behaviorally assessed sleep and susceptibility to the common cold","volume":"38","author":"A A Prather","year":"2015","journal-title":"Sleep"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4049\/jimmunol.1100015","article-title":"Sleep after vaccination boosts immunological memory","volume":"187","author":"T Lange","year":"2011","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature06685","article-title":"Haematopoietic stem cell release is regulated by circadian oscillations","volume":"452","author":"S M\u00e9ndez-Ferrer","year":"2008","journal-title":"Nature"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s42003-022-03643-y","article-title":"Hypnotic enhancement of slow-wave sleep increases sleep-associated hormone secretion and reduces sympathetic predominance in healthy humans","volume":"5","author":"L Besedovsky","year":"2022","journal-title":"Commun Biol"},{"issue":"S 03","key":"ref23","first-page":"490","article-title":"Effect of growth hormone (GH) on the immune system","volume":"1","author":"C Meazza","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"issue":"21","key":"ref24","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1182\/blood-2008-11-190769","article-title":"Cortisol and epinephrine control opposing circadian rhythms in T cell subsets","volume":"113","author":"S Dimitrov","year":"2009","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/01.HYP.30.1.71","article-title":"Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal","volume":"30","author":"C Dodt","year":"1997","journal-title":"Hypertension"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0167-5699(94)90206-2","article-title":"The influence of neuroendocrine pathways on lymphocyte migration","volume":"15","author":"C A Ottaway","year":"1994","journal-title":"Immunol Today"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"M D Taves","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCRESAHA.119.315800","article-title":"Catecholamines induce trained immunity in monocytes in vitro and in vivo","volume":"127","author":"C DCC van der Heijden","year":"2020","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"s557","DOI":"10.2741\/1054","article-title":"Thermoregulation and sleep","volume":"8","author":"P L Parmeggiani","year":"2003","journal-title":"Front Biosci"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"zsad312","DOI":"10.1093\/sleep\/zsad312","article-title":"Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank","volume":"47","author":"P F Saint-Maurice","year":"2024","journal-title":"Sleep"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"M Michaud","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsmc.2015.10.007","article-title":"Sleep duration and cardiovascular disease risk: epidemiologic and experimental evidence","volume":"11","author":"N Covassin","year":"2016","journal-title":"Sleep Med Clin"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1038\/s41598-020-67708-w","article-title":"Association between the neutrophil-to-lymphocyte ratio and obstructive sleep apnea: a meta-analysis","volume":"10","author":"M S Rha","year":"2020","journal-title":"Sci Rep"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s42003-021-02825-4","article-title":"Role of sleep deprivation in immune-related disease risk and outcomes","volume":"4","author":"S Garbarino","year":"2021","journal-title":"Commun Biol"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"M T Wallin","year":"2019","journal-title":"Neurology"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"T Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"F D Lublin","year":"1996","journal-title":"Neurology"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"T Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrneurol.2016.59","article-title":"Advanced MRI and staging of multiple sclerosis lesions","volume":"12","author":"M Absinta","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"N L Fransen","year":"2020","journal-title":"Brain"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1191\/135248506ms1320oa","article-title":"Sleep and fatigue in multiple sclerosis","volume":"12","author":"B R Stanton","year":"2006","journal-title":"Mult Scler"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5664\/jcsm.3442","article-title":"Obstructive sleep apnea and fatigue in patients with multiple sclerosis","volume":"10","author":"T J Braley","year":"2014","journal-title":"J Clin Sleep Med"},{"issue":"09","key":"ref43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.5664\/jcsm.4044","article-title":"The underdiagnosis of sleep disorders in patients with multiple sclerosis","volume":"10","author":"S D Brass","year":"2014","journal-title":"J Clin Sleep Med"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1468-1331.2007.01740.x","article-title":"High prevalence of restless legs syndrome in multiple sclerosis","volume":"14","author":"M Manconi","year":"2007","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1352458507080734","article-title":"Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage","volume":"14","author":"M Manconi","year":"2008","journal-title":"Mult Scler"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"101842","DOI":"10.1016\/j.smrv.2023.101842","article-title":"The prevalence of insomnia in multiple sclerosis: a meta-analysis","volume":"72","author":"X Zeng","year":"2023","journal-title":"Sleep Med Rev"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"e13939","DOI":"10.1111\/apha.13939","article-title":"Multiple sclerosis and circadian rhythms: can diet act as a treatment?","volume":"237","author":"O Pivovarova-Ramich","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1212\/WNL.0000000000012120","article-title":"Association of central hypersomnia and fatigue in patients with multiple sclerosis: a polysomnographic study","volume":"97","author":"A L Dubessy","year":"2021","journal-title":"Neurology"},{"issue":"09","key":"ref49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.0b013e318266fa9d","article-title":"Sleep-disordered breathing in multiple sclerosis","volume":"79","author":"T J Braley","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11910-023-01294-y","article-title":"Sleep disturbances in autoimmune neurological diseases","volume":"23","author":"L P\u00e9rez-Carbonell","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"04","key":"ref51","first-page":"367","article-title":"Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease","volume":"12","author":"L Krupp","year":"2006","journal-title":"Mult Scler"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","article-title":"Fatigue in multiple sclerosis","volume":"45","author":"L B Krupp","year":"1988","journal-title":"Arch Neurol"},{"issue":"05","key":"ref53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","article-title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","volume":"4","author":"K M Fiest","year":"2015","journal-title":"Mult Scler Relat Disord"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","article-title":"Pain associated with multiple sclerosis: systematic review and proposed classification","volume":"137","author":"A B O'Connor","year":"2008","journal-title":"Pain"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction","volume":"41","author":"S M Rao","year":"1991","journal-title":"Neurology"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/13524585231169465","article-title":"Sleep-disordered breathing and neurocognitive function in multiple sclerosis: differential associations across cognitive domains","volume":"29","author":"T R Valentine","year":"2023","journal-title":"Mult Scler"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/rep0000027","article-title":"Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis","volume":"60","author":"D Amtmann","year":"2015","journal-title":"Rehabil Psychol"},{"issue":"08","key":"ref58","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.5665\/sleep.6012","article-title":"Sleep and cognitive function in multiple sclerosis","volume":"39","author":"T J Braley","year":"2016","journal-title":"Sleep"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1352458512455958","article-title":"Impact of sleep disorder treatment on fatigue in multiple sclerosis","volume":"19","author":"I C\u00f4t\u00e9","year":"2013","journal-title":"Mult Scler"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11916-023-01115-4","article-title":"Sleep as a therapeutic target for pain management","volume":"27","author":"L Hu","year":"2023","journal-title":"Curr Pain Headache Rep"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ana.22597","article-title":"Shift work at young age is associated with increased risk for multiple sclerosis","volume":"70","author":"A K Hedstr\u00f6m","year":"2011","journal-title":"Ann Neurol"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jnnp-2022-330123","article-title":"Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study","volume":"94","author":"T \u00c5kerstedt","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"09","key":"ref63","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/1352458514563592","article-title":"Shift work influences multiple sclerosis risk","volume":"21","author":"A K Hedstr\u00f6m","year":"2015","journal-title":"Mult Scler"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.sleep.2012.11.019","article-title":"Sleep loss as risk factor for neurologic disorders: a review","volume":"14","author":"J A Palma","year":"2013","journal-title":"Sleep Med"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.4049\/jimmunol.1001026","article-title":"Dysregulation of inflammatory responses by chronic circadian disruption","volume":"185","author":"O Castanon-Cervantes","year":"2010","journal-title":"J Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000470904","article-title":"Sleep disorder as a triggering factor for relapse in multiple sclerosis","volume":"77","author":"M A Sahraian","year":"2017","journal-title":"Eur Neurol"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/13524585221144215","article-title":"Pathways between multiple sclerosis, sleep disorders, and cognitive function: longitudinal findings from The Nurses' Health Study","volume":"29","author":"T J Braley","year":"2023","journal-title":"Mult Scler"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.sleepe.2023.100071","article-title":"Sleep disturbances and progression of mobility disability: longitudinal findings from the Nurses' Health Study","volume":"4","author":"D Whibley","year":"2024","journal-title":"Sleep Epidemiol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sleep.2019.02.020","article-title":"Sleep quality can influence the outcome of patients with multiple sclerosis","volume":"58","author":"L Buratti","year":"2019","journal-title":"Sleep Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"101958","DOI":"10.1016\/j.msard.2020.101958","article-title":"Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: a pilot randomized controlled trial","volume":"40","author":"C F Siengsukon","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/13524585211010390","article-title":"Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: a randomized, double-blind, placebo-controlled trial (SAMS-PAP study)","volume":"28","author":"S Khadadah","year":"2022","journal-title":"Mult Scler"},{"issue":"14","key":"ref72","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/eurheartj\/ehy624","article-title":"The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study","volume":"40","author":"A Azarbarzin","year":"2019","journal-title":"Eur Heart J"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chest.2017.01.026","article-title":"Insomnia and risk of cardiovascular disease","volume":"152","author":"S Javaheri","year":"2017","journal-title":"Chest"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.109.901801","article-title":"Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study","volume":"122","author":"D J Gottlieb","year":"2010","journal-title":"Circulation"},{"issue":"13","key":"ref75","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"R A Marrie","year":"2010","journal-title":"Neurology"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"F Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00415-019-09230-2","article-title":"Sleep disturbances are common in patients with autoimmune encephalitis","volume":"266","author":"M S Blattner","year":"2019","journal-title":"J Neurol"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"S S Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"07","key":"ref79","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"S Jarius","year":"2023","journal-title":"J Neurol"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management","volume":"271","author":"T K\u00fcmpfel","year":"2024","journal-title":"J Neurol"},{"issue":"07","key":"ref81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"S Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"ref82","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1177\/1352458514540359","article-title":"Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody","volume":"20","author":"H Okuma","year":"2014","journal-title":"Mult Scler"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"101869","DOI":"10.1016\/j.msard.2019.101869","article-title":"Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders","volume":"38","author":"Y Beigneux","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","article-title":"Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications","volume":"66","author":"T Kanbayashi","year":"2009","journal-title":"Arch Neurol"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"S J Pittock","year":"2006","journal-title":"Arch Neurol"},{"issue":"02","key":"ref86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-009-0139-4","article-title":"Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody","volume":"256","author":"T Baba","year":"2009","journal-title":"J Neurol"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2007.11.022","article-title":"A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions","volume":"10","author":"H Nozaki","year":"2009","journal-title":"Sleep Med"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2011.08.031","article-title":"A patient with anti-aquaporin 4 antibody presenting hypersomnolence as the initial symptom and symmetrical hypothalamic lesions","volume":"312","author":"K Deguchi","year":"2012","journal-title":"J Neurol Sci"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"687536","DOI":"10.3389\/fnins.2021.687536","article-title":"Sleep disturbances in autoimmune neurologic diseases: manifestation and pathophysiology","volume":"15","author":"D Yin","year":"2021","journal-title":"Front Neurosci"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2019.11.1266","article-title":"Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD)","volume":"70","author":"V Shaygannejad","year":"2020","journal-title":"Sleep Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.sleep.2015.08.023","article-title":"Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder","volume":"17","author":"J W Hyun","year":"2016","journal-title":"Sleep Med"},{"issue":"10","key":"ref92","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"A Uzawa","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"B Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"M Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"ref95","first-page":"e1097","article-title":"Neurologic manifestations in hospitalized patients with COVID-19: The Mayo Clinic experience","volume":"97","author":"E Sechi","year":"2021","journal-title":"Neurology"},{"issue":"01","key":"ref96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-020-01905-2","article-title":"The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome","volume":"17","author":"X Liu","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"06","key":"ref98","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"L Sabater","year":"2014","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"e200353","DOI":"10.1212\/NXI.0000000000200353","article-title":"Anti-IgLON5 disease 10 years later: what we know and what we do not know","volume":"12","author":"F Graus","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"04","key":"ref100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","article-title":"Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease","volume":"146","author":"E Berger-Sieczkowski","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"09","key":"ref101","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.neurol.2024.07.004","article-title":"Clinical presentations and antibody mechanisms in anti-IgLON5 disease","volume":"180","author":"C Gaig","year":"2024","journal-title":"Rev Neurol (Paris)"},{"issue":"03","key":"ref102","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WCO.0000000000001271","article-title":"New knowledge on anti-IgLON5 disease","volume":"37","author":"C Gaig","year":"2024","journal-title":"Curr Opin Neurol"},{"issue":"06","key":"ref103","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"C Gaig","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"J A Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13311-021-01020-x","article-title":"Sleep disturbances associated with neurological autoimmunity","volume":"18","author":"M F Devine","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41386-019-0463-z","article-title":"Sleep and neurological autoimmune diseases","volume":"45","author":"A Iranzo","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"09","key":"ref107","doi-asserted-by":"crossref","first-page":"zsz133","DOI":"10.1093\/sleep\/zsz133","article-title":"Characterization of the sleep disorder of anti-IgLON5 disease","volume":"42","author":"C Gaig","year":"2019","journal-title":"Sleep"},{"issue":"18","key":"ref108","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"C Gaig","year":"2017","journal-title":"Neurology"},{"issue":"07","key":"ref109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11910-018-0848-0","article-title":"The sleep disorder in anti-lgLON5 disease","volume":"18","author":"C Gaig","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"07","key":"ref110","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00415-020-09924-y","article-title":"Early immunotherapy is highly effective in IgG1\/IgG4 positive IgLON5 disease","volume":"267","author":"T Gr\u00fcter","year":"2020","journal-title":"J Neurol"},{"issue":"06","key":"ref111","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"K A Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"107994","DOI":"10.1016\/j.clineuro.2023.107994","article-title":"Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes","volume":"234","author":"J Moura","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"issue":"05","key":"ref113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"A van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"06","key":"ref114","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE Registry","volume":"8","author":"F S Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"05","key":"ref115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/WCO.0000000000001104","article-title":"Autoimmune neuromyotonia","volume":"35","author":"L Comperat","year":"2022","journal-title":"Curr Opin Neurol"},{"issue":"01","key":"ref116","doi-asserted-by":"crossref","first-page":"e200041","DOI":"10.1212\/NXI.0000000000200041","article-title":"Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis","volume":"10","author":"J Benoit","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"ref117","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features","volume":"91","author":"S Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"04","key":"ref118","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome","volume":"267","author":"M Boyko","year":"2020","journal-title":"J Neurol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"R Liguori","year":"2001","journal-title":"Brain"},{"issue":"02","key":"ref120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"S R Irani","year":"2012","journal-title":"Ann Neurol"},{"issue":"23","key":"ref121","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/WNL.0000000000002037","article-title":"Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome","volume":"85","author":"C Laurencin","year":"2015","journal-title":"Neurology"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related Morvan syndrome: autonomic, polysomnographic, and neuropsychological observations","volume":"11","author":"P S Swayang","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"04","key":"ref123","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1388-2457(02)00022-6","article-title":"Agrypnia Excitata: a generalized overactivity syndrome and a useful concept in the neurophysiopathology of sleep","volume":"113","author":"P Montagna","year":"2002","journal-title":"Clin Neurophysiol"},{"issue":"02","key":"ref124","doi-asserted-by":"crossref","first-page":"e226832","DOI":"10.1136\/bcr-2018-226832","article-title":"Morvan's syndrome treated successfully with rituximab and lacosamide","volume":"12","author":"O Sveinsson","year":"2019","journal-title":"BMJ Case Rep"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"577028","DOI":"10.1016\/j.jneuroim.2019.577028","article-title":"Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome","volume":"336","author":"O Sveinsson","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"09","key":"ref126","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"S R Irani","year":"2010","journal-title":"Brain"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"107462","DOI":"10.1016\/j.yebeh.2020.107462","article-title":"Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: a systematic review","volume":"112","author":"K T Roberto","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"14","key":"ref128","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"A van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fneur.2020.00696","article-title":"Sleep disorders in leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated diseases","volume":"11","author":"N Lin","year":"2020","journal-title":"Front Neurol"},{"issue":"01","key":"ref130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"N R Florance","year":"2009","journal-title":"Ann Neurol"},{"issue":"03","key":"ref131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"A Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"ref132","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"J Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"04","key":"ref133","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5664\/jcsm.10448","article-title":"Narcolepsy secondary to anti-Ma2 encephalitis: two case reports","volume":"19","author":"J B Brunet de Courssou","year":"2023","journal-title":"J Clin Sleep Med"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"J Dalmau","year":"2004","journal-title":"Brain"},{"issue":"06","key":"ref135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","article-title":"REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis","volume":"30","author":"Y Compta","year":"2007","journal-title":"Sleep"},{"issue":"12","key":"ref136","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S1474-4422(20)30341-0","article-title":"Sleep disorders in autoimmune encephalitis","volume":"19","author":"A Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"J Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"24","key":"ref138","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"R H\u00f6ftberger","year":"2015","journal-title":"Neurology"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2559-7565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T22:38:47Z","timestamp":1750977527000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2559-7565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":136,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2559-7565","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}